Serum soluble fms-like tyrosine kinase-1 in the three trimesters of pregnancy: effects of maternal characteristics and medical history. (Q54290756)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Serum soluble fms-like tyrosine kinase-1 in the three trimesters of pregnancy: effects of maternal characteristics and medical history.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25678265

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25678265

title

Serum soluble fms-like tyrosine kinase-1 in the three trimesters of pregnancy: effects of maternal characteristics and medical history. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25678265

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25678265

author name string

A Tsiakkas

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25678265

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25678265

N Duvdevani

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25678265

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25678265

A Wright

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25678265

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25678265

D Wright

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25678265

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25678265

K H Nicolaides

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25678265

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25678265

publication date

30 March 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25678265

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25678265

published in

Ultrasound in Obstetrics and Gynecology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25678265

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25678265

volume

45

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25678265

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25678265

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25678265

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25678265

page(s)

584-590

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25678265

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25678265

cites work

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FUOG.14817

retrieved

21 January 2018

Circulating angiogenic factors and the risk of preeclampsia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FUOG.14817

retrieved

21 January 2018

Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FUOG.14817

retrieved

21 January 2018

Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FUOG.14817

retrieved

21 January 2018

A competing risks model in early screening for preeclampsia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FUOG.14817

retrieved

21 January 2018

Competing risks model in early screening for preeclampsia by biophysical and biochemical markers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FUOG.14817

retrieved

21 January 2018

Competing risks model in screening for preeclampsia by maternal characteristics and medical history.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FUOG.14817

retrieved

21 January 2018

A CRITICAL EVALUATION OF SONAR "CROWN-RUMP LENGTH" MEASUREMENTS

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FUOG.14817

retrieved

21 January 2018

Fetal biometry at 14-40 weeks' gestation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FUOG.14817

retrieved

21 January 2018

Birthweight with gestation and maternal characteristics in live births and stillbirths

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FUOG.14817

retrieved

21 January 2018

Identifiers

DOI

10.1002/UOG.14817

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25678265

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25678265

PubMed publication ID

25678265

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25678265

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/25678265

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54290756&oldid=861921097"